Iceland· IS-EU/1/19/1390/001-004
Inbrija
A levodopa product containing levodopum inn, registered in Iceland by Merz Therapeutics GmbH. The same ATC class is registered in 12 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Levodopa is registered in 12 of 19 countries.
Countries holding a registration under ATC N04BA01 (levodopa), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Levodopa · ATC N04BA01
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of levodopa costs, country by country.
Normalised to the WHO defined daily dose (3.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Levodopa · price per daily dose (3.5 g)
USD · FX 28 Sept 2026
- ES Spain$465.34
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Levodopum INN
- Manufacturer
- Merz Therapeutics GmbH
- Country
- Iceland (IS)
- ATC code
- N04BA01
- ATC class
- Levodopa
- Defined daily dose
- 3.5 g, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean07350992 stk x1 þpakkiISK 73345
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
140 interactions on record for levodopa.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levodopa · interactions on record
140 records
- 4 severe
- 122 moderate
- 14 minor
Most severe, free to view
- ProcarbazineL01XB01severe
- OzanimodL04AA38severe
- OzanimodL04AE02severe
- Methylthioninium chlorideV03AB17severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Levodopa in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaINBRIJAMerz Therapeutics GmbH, Frankfurt am Main
- SpainINBRIJA 33 MG POLVO PARA INHALACION CAPSULAS DURASMerz Therapeutics Gmbh
- FinlandInbrijaMerz Therapeutics GmbH
- United KingdomInbrija 33mg inhalation powder capsules with deviceMerz Pharma UK Ltd
- IrelandInbrija 33 mg inhalation powder, hard capsulesMerz Pharmaceuticals GmbH
- NetherlandsInbrija 33 mg inhalatiepoeder, harde capsulesMerz Therapeutics GmbH
- PolandInbrijaAcorda Therapeutics Ireland Limited
- BelgiumInbrija 33 mgMerz Therapeutics
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Inbrija
- Liechtenstein · Inbrija
- Norway · Inbrija
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5ac4b73b-4285-48d5-8bb5-0639e3260e78 GET /v1/drugs/5ac4b73b-4285-48d5-8bb5-0639e3260e78?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Innöndunarduft, hart hylki",
"source": "lyfjastofnun",
"atc_raw": "N04BA01",
"marketed": true,
"strength": "33 mg",
"ma_number": "EU/1/19/1390/001-004",
"substance": "Levodopum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "43727"
}See everything about levodopa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.